Far from being sharply divided, the American people are in broad support of more stem cell research, according to the results of an online survey released today by Cord Blood Registry® (CBR®) to coincide with National Cord Blood Awareness Month.
The survey found that nearly 9 of 10 Americans either agree or strongly agree that further research should be conducted to investigate the potential of stem cells to stimulate the body’s own repair mechanisms to heal tissues or organs. In addition, the survey results indicate that more than 75% of Americans are aware of stem cell research to develop more effective treatments for conditions and diseases such as Alzheimer’s, brain injury, and cancer. The survey also shows that 8 in 10 Americans believe in the medical benefits of stem cell research and would like to learn more about therapeutic strategies which augment, repair, replace or regenerate organs and tissues.
Other key findings of the survey include:
- Nearly 75% of Americans believe cord blood banking is a good investment in their families’ health
- Nearly 50% of Americans believe they will personally benefit from cord blood stem cell research
- Over 50% of Americans would recommend cord blood banking to others
Because a person’s own (autologous) stem cells can be infused back into that individual without being rejected by the body’s immune system, autologous cord blood stem cells have become an increasingly important focus of regenerative medicine research. Regenerative medicine is the process of replacing or regenerating human cells, tissues or organs to restore or establish normal function. It is estimated that nearly 1 in 3 people in the United States may benefit from regenerative medicine therapy.
Researchers are exploring the use of cord blood stem cells in a number of regenerative medicine applications, such as cardiovascular repair to observe whether cells selectively migrate to injured cardiac tissue, enhance blood flow at the site of injury, and improve overall heart function. Additionally, researchers are investigating central nervous system therapies to assess whether cells migrate to the area of brain injury alleviating mobility related symptoms, and repair damaged brain tissue, such as that experienced with cerebral palsy. It is believed that cord blood stem cells will be an important resource as medicine advances toward harnessing the body’s own cells for treatment.
Survey research and graphics were designed and executed by G&C Strategy, an independent market and consumer research consultancy, specializing in consumer research and business strategy in e-commerce, technology, consumer packaged goods, mobile, biotechnology, and food/beverage. Research data was collected in May 2014 via an online survey of 1,130 adults, age 18 years and older, from across the country. Survey respondents do not have an affiliation with CBR or its partners.
About Cord Blood Registry
Cord Blood Registry® (CBR®) is the world’s largest newborn stem cell company. Founded in 1992, CBR is entrusted by parents with storing more than 500,000 cord blood and cord tissue units. CBR is dedicated to advancing the clinical application of newborn stem cells by partnering with leading research institutions to establish FDA-regulated clinical trials, requiring CBR processed cord blood, for conditions that have no cure today. For more information, visit cordblood.com